The sIL-2R level in patients referred with a suspicion of Complex Regional Pain Syndrome. Comparison between those who are diagnosed with CRPS and those who are not.

The sIL-2R level in patients referred with a suspicion of Complex Regional Pain Syndrome. Comparison between those who are diagnosed with CRPS and those who are not. - ImPaCt

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44506

Enrollment

Registered

2018-01-16

Start date

2018-03-06

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regionaal Pijn Syndroom. Reflex Sympathetic Dystrophy Sudeck's Atrophy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who are referred to the Center for Pain Medicine with a suspicion of CRPS. Age * 18 years. Only one limb is affected.

Exclusion criteria

Exclusion criteria: History of an auto-inflammatory or autoimmune disease. Current treatment with immunomodulating medication or treatment within the last 6 months. Ill at the time of visit or recently been ill in the past two weeks. Knowledge of or confirmed pregnancy.

Design outcomes

Primary

Measure	Time frame
The main study parameter is the blood sIL-2R level between patients diagnosed with CRPS and the patients who are not diagnosed with CRPS.	—

Secondary

Measure	Time frame
Association between the sIL-2R level and CRPS severity score.	—

Countries

Netherlands

Outcome results